2595 studies found for:    "Fibrin Modulating Agents"
Show Display Options
Rank Status Study
1 Completed Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Conditions: Shoulder Joint Disease;   Complications; Arthroplasty;   Intraoperative Complications;   Blood Loss, Surgical
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
2 Completed Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement
Condition: Osteoarthritis
Interventions: Drug: Tranexamic Acid (TXA);   Drug: ε-Aminocaproic Acid (EACA)
3 Recruiting STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Conditions: Intracerebral Haemorrhage;   Stroke
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
4 Terminated The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
Condition: Stroke, Acute
Interventions: Device: hypothermia;   Other: Group1: IV t-PA and normothermia
5 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
6 Completed Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke Patients
Conditions: Stroke;   Immunoregulation;   Inflammation;   Vinpocetine
Interventions: Drug: vinpocetine;   Drug: Aspirin
7 Recruiting Tranexamic Acid in Revision Total Joint Arthroplasty
Conditions: Revision Total Knee Arthroplasty;   Revision Total Hip Arthroplasty;   Acute Blood Loss Anemia
Interventions: Procedure: Revision Total Knee Arthroplasty (TKA);   Procedure: Revision Total Hip Arthroplasty (THA)
8 Not yet recruiting Defibrotide in the Human Endotoxemia Model --‐ an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide
Conditions: Healthy Volunteers;   Endotoxemia
Interventions: Drug: Defibrotide;   Drug: Placebo (0.9% sodium chloride);   Drug: Lipopolysaccharide
9 Recruiting Risk Factors for Vascular Calcifications in Hemodialysis Patients: to What Extent is Vitamin K2 Deficiency Involved?
Condition: Vascular Calcifications
Intervention: Drug: Menaquinone
10 Completed Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave Lithotripsy
Conditions: Urolithiasis;   Renal Hematoma
Interventions: Drug: Acetylsalicylic acid;   Drug: low molecular weight heparin
11 Recruiting Treatment to Reduce Vascular Calcification In Hemodialysis Patients Using Vitamin K
Conditions: Vascular Calcification;   Systemic and Arterial Stiffness;   Complication of Hemodialysis;   Deficiency of Vitamin K2
Intervention: Drug: menaquinone-7
12 Not yet recruiting Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke
Condition: Ischemic Stroke
Interventions: Drug: clopidogrel;   Drug: Aspirin
13 Not yet recruiting Tranexamic Acid and Blood Clots in Knee Surgery
Condition: Venous Thrombosis
Intervention: Drug: Tranexamic Acid
14 Not yet recruiting Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist
Condition: Intracerebral Hemorrhage
Interventions: Drug: Tranexamic acid;   Drug: Saline 0.9%
15 Not yet recruiting Impact of isoQUercetin and Aspirin on Platelet Function
Condition: Cardiovascular Disease
Interventions: Drug: Vehicle control;   Drug: Isoquercetin;   Drug: Aspirin;   Drug: Isoquercetin plus Aspirin
16 Not yet recruiting Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Condition: Atrial Fibrillation
Interventions: Drug: Edoxaban;   Drug: Clopidogrel;   Drug: Prasugrel;   Drug: ticagrelor
17 Not yet recruiting Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty
Condition: Osteoarthritis, Knee
Interventions: Drug: Topical tranexamic acid;   Drug: Floseal®;   Drug: Enoxaparin
18 Not yet recruiting Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
Condition: Atrial Fibrillation
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Vitamin K antagonists;   Drug: dabigatran (Pradaxa)
19 Recruiting Intravenous Versus Topical Administration of Low Dose Epinephrine Plus Combined Administration of Intravenous and Topical Tranexamic Acid (TXA)for Primary Total Hip Arthroplasty
Condition: Blood Loss
Interventions: Drug: Tranexamic acid (TXA);   Drug: Epinephrine
20 Completed Biological and Clinical Measurements Following Systemic Leakage When a Citrate or Heparin Lock is Used
Condition: Acute Renal Insufficiency
Interventions: Drug: citrate 4%;   Drug: unfractionated heparin;   Biological: blood sample

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years